Log in to search using one of your social media accounts:

 

An epigenetic tactic to treat RMS
BET inhibitors may be an effective treatment for some rhabdomyosarcomas. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - August 29, 2017 Category: Science Authors: Ferrarelli, L. K. Tags: STKE Editors ' Choice Source Type: news

Combining immunotherapies effective against mouse model of cancer
(Nationwide Children's Hospital) A recent study by researchers at The Research Institute at Nationwide Children's Hospital points to a new treatment strategy for rhabdomyosarcoma that takes advantage of the body's own immune response. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 19, 2017 Category: International Medicine & Public Health Source Type: news

Now Is The Time-Pitch In
I recently blogged about the political climate, about staying focused on an issue, and not getting distracted by partisan political "religions" and finding a way of working together for the greater good. That greater good in my life is, of course, Less Cancer -- the goal of actually reducing the low-hanging, preventable incidences of cancer. Cancer is something that has touched almost all of us personally. We understand that Cancer is a large umbrella term, encompassing dozens of diseases; we also know that over 50% of all cancers are preventable. The American Association for Cancer Research tells us in it...
Source: Healthy Living - The Huffington Post - January 27, 2017 Category: Consumer Health News Source Type: news

Mother reveals how her intuition led to her baby's Rhabdomyosarcoma cancer diagnosis
Baby Penelope was born with a bruised lump on her back, which grew bigger over time. Doctors told her worried mother Emily, from NSW, that it was reflux, colic or constipation, (Source: the Mail online | Health)
Source: the Mail online | Health - December 21, 2016 Category: Consumer Health News Source Type: news

No one would listen to me': Mother reveals how her intuition led to her baby girl rare Rhabdomyosarcoma cancer diagnosis... despite doctors insisting she only had 'reflux'
Baby Penelope was born with a bruised lump on her back, which grew bigger over time. Doctors told her worried mother Emily, from NSW, that it was reflux, colic or constipation, (Source: the Mail online | Health)
Source: the Mail online | Health - December 20, 2016 Category: Consumer Health News Source Type: news

Welsh boy shown wiped out after having chemotherapy to help battle his rare form of cancer
Logan Sellers, from Bangor, Wales, was diagnosed with rhabdomyosarcoma after a lump developed behind his eye. But his condition has become so bad that he often turns down food. (Source: the Mail online | Health)
Source: the Mail online | Health - December 5, 2016 Category: Consumer Health News Source Type: news

More boys are diagnosed with cancer than girls worldwide - why?
This article was originally published on The Conversation. Read the original article. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website. (Source: Science - The Huffington Post)
Source: Science - The Huffington Post - November 25, 2016 Category: Science Source Type: news

Dad Captures The Effects Of Childhood Cancer With One Moving Photo
In one photo, Andrew Brown has captured the effects of childhood cancer as well as the strength of his daughter. On June 23, doctors at a hospital in Australia diagnosed Brown’s daughter Hayley with a type of cancer called rhabdomyosarcoma. Brown told The Huffington Post that doctors found a soft tissue tumor at the back of Hayley’s nose that was filling her nasal passage. The tumor was affecting one of her eyes as well as her brain, so Hayley began different forms of chemotherapy just two days after her diagnosis. “[The tumor] was also starting to put pressure on the bottom of her brain so they wanted to...
Source: Healthy Living - The Huffington Post - November 4, 2016 Category: Consumer Health News Source Type: news

Seven-year-old 's rare cancer was detected during a play fight with her brother
Aaron East, 11, was playing with his sister Amy, 7, at their home in Chelmsford, Essex when he noticed the growth in her throat. Tests revealed it was rhabdomyosarcoma - a rare soft tissue cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - August 10, 2016 Category: Consumer Health News Source Type: news

First cancer patient in Ohio receives proton therapy treatment
( University Hospitals Case Medical Center ) Mevion Medical Systems, the leader in compact proton therapy, is announcing that University Hospitals in Cleveland used the industry-leading MEVION S250 proton therapy system to treat its first patient, a 24-year-old woman with, rhabdomyosarcoma, a rare form of sarcoma. The proton therapy treatment made history by being the first in the state of Ohio. The new proton therapy center is located on the main campus of UH, directly between UH Rainbow Babies & Children's Hospital and UH Seidman Cancer Center. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 27, 2016 Category: Cancer & Oncology Source Type: news

What Are The Most Common Pediatric Cancers?
Discussion Cancer occurs in all ages including children. Fortunately cancer is much less common in the pediatric age group accounting for
Source: PediatricEducation.org - July 4, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Nadia Hobbs with throbbing pain in her jaw had a tumour the size of gobstopper
Nadia Hobbs, 18, from St Thomas, Exeter, was found to have rhabdomyosarcoma, a rare and aggressive cancer of the body's soft tissues in the left side of her jaw. (Source: the Mail online | Health)
Source: the Mail online | Health - March 17, 2016 Category: Consumer Health News Source Type: news

Navidea begins patient enrolment in paediatric trial of lymphoseek to treat solid tumours
Ireland-based Navidea Biopharmaceuticals has started patient enrolment in a clinical trial comparing Lymphoseek (technetium Tc 99m tilmanocept) injection and vital blue dye (VBD) in children with melanoma, rhabdomyosarcoma, or other solid tumours. (Source: Drug Development Technology)
Source: Drug Development Technology - January 7, 2016 Category: Pharmaceuticals Source Type: news

New test could help personalize treatment for common childhood cancer
(Institute of Cancer Research) A new gene test can identify which patients are likely to suffer more aggressive forms of the childhood cancer rhabdomyosarcoma, new research reports. Examining the activity of only five genes in a sample of the tumor was enough to identify high-risk children who might benefit from more intensive treatment or from new therapies in clinical trials. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 15, 2015 Category: Cancer & Oncology Source Type: news

Rhabdomyosarcoma Therapeutic Development and Pipeline Market Review H1...
RnRMarketResearch.com adds “Rhabdomyosarcoma – Pipeline Review, H1 2015” to its store. The report provides an overview of the Rhabdomyosarcoma’s therapeutic pipeline.(PRWeb April 22, 2015)Read the full story at http://www.prweb.com/releases/rhabdomyosarcoma/pipeline-review-h1-2015/prweb12672220.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 23, 2015 Category: Pharmaceuticals Source Type: news

Rhabdomyosarcoma Therapeutic Pipeline Review H2 2014 Report at...
ReportsnReports.com adds “Rhabdomyosarcoma - Pipeline Review, H2 2014” to its store. The report provides an overview of the Rhabdomyosarcoma therapeutic pipeline.(PRWeb January 03, 2015)Read the full story at http://www.prweb.com/releases/rhabdomyosarcoma-pipeline/review-h2-2014-report/prweb12419753.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 4, 2015 Category: Pharmaceuticals Source Type: news

New Drug Combos Promising in Higher-Risk RhabdomyosarcomaNew Drug Combos Promising in Higher-Risk Rhabdomyosarcoma
Temsirolimus combined with chemotherapy increased event-free survival in rhabdomyosarcoma, but the addition of irinotecan did not improve outcomes, new research shows. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 5, 2014 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Scientists map gene changes driving tumors in common pediatric soft-tissue cancer
Scientists have mapped the genetic changes that drive tumors in rhabdomyosarcoma, a pediatric soft-tissue cancer, and found that the disease is characterized by two distinct genotypes. The genetic alterations identified in this malignancy could be useful in developing targeted diagnostic tools and treatments for children with the disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 23, 2014 Category: Science Source Type: news

NIH scientists map gene changes driving tumors in common pediatric soft-tissue cancer
(NIH/National Cancer Institute) Scientists have mapped the genetic changes that drive tumors in rhabdomyosarcoma, a pediatric soft-tissue cancer, and found that the disease is characterized by two distinct genotypes. The genetic alterations identified in this malignancy could be useful in developing targeted diagnostic tools and treatments for children with the disease. The study, by researchers at the National Cancer Institute, part of the National Institutes of Health, and their colleagues, appeared in the Jan. 23, 2014, issue of the journal Cancer Discovery. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 23, 2014 Category: Biology Source Type: news

JCI early table of contents for Dec. 16, 2013
(Journal of Clinical Investigation) This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online Dec. 16, 2013 in the JCI: "A mouse model to evaluate potential age-promoting compounds," "Hybrid protein deregulates complement in dense deposit disease," "Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity," "Alveolar rhabdomyosarcoma-associated PAX3-FOXO1 promotes tumorigenesis via Hippo pathway suppression," "Nervous glucose sensing regulates postnatal beta cell proliferation and gluc...
Source: EurekAlert! - Cancer - December 16, 2013 Category: Cancer & Oncology Source Type: news

Drugs identified that enhance oxidative stress as possible weapon against most common pediatric soft tissue tumor
Drugs that enhance a process called oxidative stress were found to kill rhabdomyosarcoma tumor cells growing in the laboratory and possibly bolstered the effectiveness of chemotherapy against this aggressive tumor of muscle and other soft tissue. The findings are the latest from the St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project and appear in the December 9 edition of the scientific journal Cancer Cell.Oxidative stress is caused when oxygen-free radicals and other byproducts of cell metabolism build up in cells. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 12, 2013 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Gene sequencing project finds family of drugs with promise for treating childhood tumor
(St. Jude Children's Research Hospital) Drugs that enhance a process called oxidative stress were found to kill rhabdomyosarcoma tumor cells growing in the laboratory and possibly bolstered the effectiveness of chemotherapy against this aggressive tumor of muscle and other soft tissue. The findings are the latest from the St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project and appear in the Dec. 9 edition of the scientific journal Cancer Cell. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 9, 2013 Category: Global & Universal Source Type: news

Combination therapy could treat common children's cancer
A dual-pronged strategy using two experimental cancer drugs together could successfully treat a childhood cancer by inhibiting tumour growth and blocking off the escape routes it uses to become resistant to treatment, finds a new study. Scientists at The Institute of Cancer Research, London, found that combining two separate molecularly targeted therapies could stop processes driving growth in a cancer called rhabdomyosarcoma, a major cause of cancer death in children... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 5, 2013 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Dense Embryonal or Alveolar Rhabdomyosarcoma?Dense Embryonal or Alveolar Rhabdomyosarcoma?
The authors elucidate the differentiation of alveolar and embryonal rhabdomyosarcoma variants utilizing both histology and evaluation of fusion status. American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 23, 2013 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

Slide Show: Nasal Tumors
This nasal tumor slide show features pathology images of nasal neuroblastoma, rhabdomyosarcoma, melanoma, hemangiopericytoma, and lymphoma at various magnifications. (Source: Cancer Network)
Source: Cancer Network - September 12, 2013 Category: Cancer & Oncology Source Type: news

EMA opens public consultation on standard paediatric investigation plans for two types of cancer in children
Source: EMA Area: News The European Medicines Agency has opened a public consultation on two standard paediatric investigation plans (PIPs) for two specific types of cancer with unmet medical needs in children, acute myeloid leukaemia and rhabdomyosarcoma.   A PIP sets out a programme for the development of a medicine to ultimately authorise its use in children. The goal of these standard PIPs is to support pharmaceutical companies to propose a plan that is scientifically adapted to the medicine.   Compared to the progress made in other acute leukaemias, the outlook for children with myeloid leukaemia is...
Source: NeLM - News - February 22, 2013 Category: Drugs & Pharmacology Source Type: news